Efficacy of topical imiquimod 3.75% in the treatment of actinic keratosis of the scalp in immunosuppressed patients: our case series

Efficacy of topical imiquimod 3.75% in the treatment of actinic keratosis of the scalp in immunosuppressed patients: our case series

Background: Actinic keratoses (AK) represent common cutaneous lesions, appearing in ‘Field cancerization areas’ and potentially evolving toward invasive neoplasm. Immunosuppressed patients frequently develop numerous and aggressive AKs. Aim: In this observational study, we report our experience with...

Full description

Bibliographic Details
Main Authors: E. Zavattaro, F. Veronese, G. Landucci, V. Tarantino, P. Savoia
Format: Article
Language:English
Published: Taylor & Francis Group 2020-04-01
Series:Journal of Dermatological Treatment
Subjects:
actinic keratosis
immunosuppression
field cancerization
Online Access:http://dx.doi.org/10.1080/09546634.2019.1590524

Internet

http://dx.doi.org/10.1080/09546634.2019.1590524

Similar Items